Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1245
Full metadata record
DC FieldValueLanguage
dc.contributor.authorM.B.Rakhimova, Kh.S.Akhmedov, Y.A.Turaev-
dc.date.accessioned2021-12-28T10:26:16Z-
dc.date.available2021-12-28T10:26:16Z-
dc.date.issued2021-
dc.identifier.issn2249-7137-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/1245-
dc.description.abstractThe main purpose of this work was to substantiate the feasibility and possible directions of the influence of means of pharmacological correction of endothelial dysfunction for the prevention of pathological conditions associated with a new coronavirus infection. The analysis of the available literature on the functions of the endothelium was carried out, the study of foreign and domestic experience on the possible directions of pharmacological correction of endothelial dysfunction was carried out. A review of the available literature data on endothelial dysfunction with substantiation of the role vascular endothelial damage as one of the central links in the pathogenesis of acute respiratory distress syndrome is presented.en_US
dc.language.isoenen_US
dc.subjectAnkylosing spondylitis, Asymmetric dimethylarginine, homocysteine, endothelial dysfunction, cardiovascular pathology, COVID-19.en_US
dc.titleEndothelial dysfunction as a link in the pathogenesis of ankylosing spondylitis against the backgrouRakhimovand of a new coronavirus infectionen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.